>COLY – It seems Pfizer were not so tight concerning the chemo trial results.<
It’s very much harder to prevent leakage of clinical-trial results than it is to prevent leakage of a buyout. It’s hard to say that PFE was at fault for leakage of the NSCLC results.
Market Data 
Markets 
AI
